Sankyo Co. Newsletter
-
Patient Deaths Put Merck, Daiichi Sankyo’s Antibody-Drug Conjugate on Hold
19 Dec 2025 13:49 GMT
… hold on Merck and Daiichi Sankyo’s late-stage development … IDeate-Lung02, which prompted Daiichi Sankyo to voluntarily halt recruitment. The … study.
Merck and Daiichi Sankyo teamed up in October 2023 … into the promise of Daiichi Sankyo’s DXd platform. The …
-
<![CDATA[Gedatolisib Combo With/Without Palbociclib May Be New SOC in PIK3CA Wild-Type Breast Cancer]]>
21 Dec 2025 20:08 GMT
… (institutional), Pierre Fabre (personal), Daiichi Sankyo (institutional/personal), and Olema … ) was provided by AstraZeneca, Daiichi Sankyo, Gilead, Seagen, and MSD. … by AstraZeneca, Gilead, MSD, Daiichi Sankyo, Accord, and Pfizer.
References
Pistilli …
-
<![CDATA[Analysis Sheds Light on Dosing Patterns of Ponatinib in Patients With CP-CML in the United States]]>
21 Dec 2025 03:36 GMT
… with Incyte, Terns, and Daiichi Sankyo.
References
Liu W, Reddick LE …
-
<![CDATA[T-DXd Improves iDFS Across HER2+ Early Breast Cancer Subgroups]]>
20 Dec 2025 00:41 GMT
… , Celgene, Bristol Meyers Squibb, Daiichi Sankyo, Exact Science, Gilead, GSK, Incyte … ;or travel support from Daiichi Sankyo, European Society of Medical Oncology …
-
Patient deaths put Merck, Daiichi’s ADC trial on partial hold
20 Dec 2025 01:48 GMT
… Merck & Co. and Daiichi Sankyo’s antibody-drug conjugates following …
-
Patient deaths prompt halt in Merck-Daiichi phase III in lung cancer
19 Dec 2025 22:02 GMT
Daiichi Sankyo Inc. told BioWorld it voluntarily …
-
Fierce Pharma Asia—Daiichi ADCs' 1st-line nod, trial deaths; Takeda's TYK2 trial win
19 Dec 2025 18:29 GMT
… news roundup of 2025, Daiichi Sankyo scored a key FDA approval … has approved AstraZeneca and Daiichi Sankyo’s Enhertu in combination with …
-
VIDEO: No ‘major improvement’ in PFS with sacituzumab-govitecan in breast cancer subset
19 Dec 2025 18:34 GMT
… ;funding from AstraZeneca and Daiichi Sankyo and consulting/advisory board … from AstraZeneca, Casdin Capital, Daiichi Sankyo, Eli Lilly and Co., Hightop …
-
BMS’ Cobenfy TV ad is latest target of FDA untitled letter spree
19 Dec 2025 18:29 GMT
… posted missives to AstraZeneca, Daiichi Sankyo, SK Life Science and PharmaTher …
-
A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and Outcomes
19 Dec 2025 14:01 GMT
… , Abbvie, AstraZeneca, BMS, Ono, Daiichi-Sankyo, Janssen, and Chugai/Roche … with AstraZeneca, Boerhinger Ingelheim, Daiichi Sankyo, Merck, Amgen, MSD, Roche, Pfizer … from AstraZeneca, Boerhinger Ingelheim, Daiichi Sankyo, Merck, Amgen, MSD, Roche, Pfizer …
About
© 1995-2025